Harvey Tran, MD

Bioprinting and Tissue Engineering: A Regenerative Investment Landscape

Evergrowth BioHealthcare Capital recognizes the convergence of bioprinting and tissue engineering as a disruptive force in regenerative medicine. This innovative field combines 3D printing technology with biological materials to create functional tissues and organs, offering transformative potential for healthcare and beyond. Investment Opportunities: As a forward-thinking investment firm, Evergrowth BioHealthcare Capital views bioprinting and tissue...

Read More

Transforming Healthcare Delivery – A High-Growth Investment Opportunity

Evergrowth Biohealthcare Capital recognizes the immense potential of digital health to reshape the healthcare landscape. We are actively seeking investment opportunities in companies that are developing innovative digital health solutions that are: Evergrowth BioHealthcare Capital is committed to supporting the innovators driving the digital transformation of healthcare. We offer not only financial resources but also...

Read More

How CAR-T Cell Therapy Works

Evergrowth BioHealthcare Capital is investing in the groundbreaking potential of CRISPR/Cas9 technology to revolutionize cancer immunotherapy. By precisely editing the genes of immune cells, CRISPR enables the development of therapies that enhance their ability to target and eliminate cancer cells with unprecedented precision. This targeted approach promises to improve treatment outcomes, reduce side effects, and...

Read More

The Abrahamic Business Circle Investors Roundtable in Vienna, Austria

The vibrant city of Vienna, Austria, recently played host to an influential gathering of business leaders and investors at The Abrahamic Business Circle Investors Roundtable. This event brought together a diverse group of professionals committed to fostering economic diplomacy and collaboration across various sectors. One of the event’s highlights was the opportunity for attendees to...

Read More